Based on the updated Guidance document Product information for human medicinal products as of 01.03.2023, the two detailed templates Patient information for herbal medicinal products and Patient information for homeopathic and anthroposophic medicinal products have been updated and better structured and will be valid from 15.03.2023 onwards.
The templates are based on the requirements of the Ordinance of the Swiss Agency for Therapeutic Products on the Requirements for the Authorisation of Medicinal Products (SR 812.212.22; AMZV). For medicinal products for gemmotherapy with indication and Asian medicinal products with indication, the template Patient information for homeopathic and anthroposophic medicinal products is to be used.